Brevan Howard Capital Management LP Verve Therapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 67,013 shares of VERV stock, worth $745,854. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,013Holding current value
$745,854% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding VERV
# of Institutions
201Shares Held
85.1MCall Options Held
350KPut Options Held
186K-
Alphabet Inc. Mountain View, CA12.2MShares$135 Million8.86% of portfolio
-
Bvf Inc San Francisco, CA6.9MShares$76.8 Million1.39% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$73.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.19MShares$46.7 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY4MShares$44.5 Million2.14% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $667M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...